Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery

New England Journal of Medicine

Volumn 345, Issue 18, 2001, Pages 1298-1304

  Eriksson, Bengt I ^a   Bauer, Kenneth A ^b   Lassen, Michael R ^c   Turpie, Alexander G G ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HillerØd University   (Denmark)

^d HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HIP FRACTURE; HIP SURGERY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE CARE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

AGED; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HIP FRACTURES; HUMANS; INCIDENCE; INJECTIONS, SUBCUTANEOUS; MALE; MORTALITY; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0035522302     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011100     Document Type: Article

References (39)

1. Prevention of venous thrombo-embolism
2. Prevention of venous thromboembolism: International consensus statement: Guidelines compiled in accordance with the scientific evidence
3. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: A prospective, randomized study of compression alone versus no prophylaxis
4. Cyclic sequential compression of the lower limbs in prevention of deep venous thrombosis
5. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures
6. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture
7. Thromboembolic complications after hip fracture - Prophylaxis with low molecular weight-vs. unfractionated heparin
8. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur
9. Thromboprophylaxis in hip fracture surgery: A pilot study comparing danaparoid, enoxaparin and dalteparin
10. Early preoperative thromboprophylaxis with Klexane in hip fracture surgery: A placebo-controlled study
11. A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture
12. Thromboprophylaxis in patients with hip fractures: A prospective, randomized, comparative study between ORG 10172 and dextran 70
13. Low-molecular-weight heparinoid Orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture
14. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip: A prospective, randomized trial
15. Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur: A controlled clinical trial using venous phlebography
16. Venous thrombosis in patients with fracture of the upper end of the femur: A phlebographic study of the effect of prophylactic anticoagulation
17. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip
18. Prophylaxis against thrombosis in femoral neck fractures - A comparison between dextran 70 and dicumarol
19. An evaluation of early thrombosis prophylaxis following fracture of the femoral neck: A comparison between dextran and dicoumarol
20. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
21. Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
22. Chemical synthesis of glycosaminoglycans: New approaches to antithrombotic drugs
23. The unique antithrombin III binding domain of heparin: A lead to new synthetic antithrombotics
24. The effect of the synthetic pentasaccharide SR 90107/ORG31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa
25. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity
26. A synthetic pentasaccharide for the prevention ofdeep-vein thrombosis after total hip replacement
27. Roentgen diagnosis of venous thrombosis in the leg
28. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
29. Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393
30. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
31. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind randomized comparison
32. Deep vein thrombosis and pulmonary embolism: An autopsy study with multiple regression analysis of possible risk factors
33. Is embolic risk conditioned by location of deep venous thrombosis?
34. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement: Comparison of low-molecular-weight heparin and unfractionated heparin
35. The PENTAMAKS Study: Comparison of the first synthetic factor Xa inhibitor with low molecular weight heparin in the prevention of venous thromboembolism (VTE) after elective major knee surgery
36. The EPHESUS Study: Comparison of the first synthetic factor Xa inhibitor with low molecular weight heparin (LMWH) in the prevention of venous thromboembolism (VTE) after elective hip replacement surgery
37. The PENTATHLON 2000 Study: Comparison of the first synthetic factor Xa inhibitor with low molecular weight heparin in the prevention of venous thromboembolism (VTE) after elective hip replacement surgery
38. Place of aspirin in prophylaxis of venous thromboembolism
39. PEP trial